EZH2 and colonic neoplasm: In colon cancer stages II and III, there were trends for better RFS (P=0.077) and CSS (P=0.085) with a high EZH2 index in patients receiving adjuvant chemotherapy (Figure 3, panel E), but not in patients with no adjuvant therapy (Figure 3, panel F).